Kalb Michael Wayne

CIK 0001678248

SVP and CFO

Filings

Latest Jan 6, 2026

Issuers covered

Showing

11 of 11

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Kalb Michael Wayne. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Kalb Michael Wayne has filed

Ticker	Issuer	Filings	Last filed
AMRN	Amarin Corp Plc\uk	4	Mar 2, 2022
CPRX	Catalyst Pharmaceuticals, Inc.	4	Jan 6, 2026
CINC	Cincor Pharma, Inc.	2	Feb 24, 2023
IMPL	Impel Pharmaceuticals Inc	1	May 12, 2023

11 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jan 6, 2026	CPRXCatalyst Pharmaceuticals, Inc.	MExercise	7,139	-	-
Nov 24, 2025	CPRXCatalyst Pharmaceuticals, Inc.	MExercise	6,894	-	-
Jan 3, 2025	CPRXCatalyst Pharmaceuticals, Inc.	MExercise	7,138	-	-
Nov 25, 2024	CPRXCatalyst Pharmaceuticals, Inc.	Holdings only	-	-	-
May 12, 2023	IMPLImpel Pharmaceuticals Inc	Holdings only	-	-	-
Feb 24, 2023	CINCCincor Pharma, Inc.	DDisposition	202,437	-	-
Jan 30, 2023	CINCCincor Pharma, Inc.	AGrant	177,000	-	-
Mar 2, 2022	AMRNAmarin Corp Plc\uk	FTax	6,213	$3.27	$20,317
Feb 8, 2022	AMRNAmarin Corp Plc\uk	Holdings only	-	-	-
Feb 2, 2022	AMRNAmarin Corp Plc\uk	FTax	5,317	$3.36	$17,865
Jan 4, 2022	AMRNAmarin Corp Plc\uk	FTax	25,379	$3.35	$85,020

Showing 1-11 of 11

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.